Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
mTOR Levels and Metastasis in Luminal Breast Cancer: Implications for Prognosis and Treatment
Hasan Nur M.M.
Asian Pacific Journal of Cancer Prevention
Q2Published: 2025Citations: 1
Abstract
Increased serum mTOR levels (≥13.32 ng/mL) are significantly linked to the presence of metastasis, particularly in HER2-positive BC. These findings suggest serum mTOR as a promising biomarker for metastasis risk and a potential therapeutic target in luminal BC.
Access to Document
10.31557/APJCP.2025.26.9.3347Other files and links
- Link to publication in Scopus
- Open Access Version Available
Fingerprint
PI3K/AKT/mTOR pathwaySciences
MedicineSciences
MetastasisSciences
Discovery and development of mTOR inhibitorsSciences
BiomarkerSciences
Cancer researchSciences
OncologySciences
Internal medicineSciences
Distant metastasisSciences
Breast cancerSciences